Registration Options

Activity Dates: 11/06/2020 - 05/06/2021

Members can access this product for only $80. Log in or Join now!

Target Audience

This self-study activity serves as an educational tool for pharmacists seeking Board Certified Psychiatric Pharmacist (BCPP) Recertification credit and other pharmacists and health care providers seeking advanced education in patient and disease state management in the field of psychiatric pharmacy.

Content

This recertification product consists of four clinical review articles focused on single disorders, or on one or more distinct aspects of a single psychiatric, neurologic, or substance use disorder. Authored by leading experts in the field and hosted in CPNP’s peer-reviewed journal, The Mental Health Clinician (MHC), these case-based articles will be fully referenced and offer therapeutic advice based on both evidence and longstanding clinical experience. Pearls articles focus on aspects of disease states and their pharmacotherapy that require synthesis of solutions to problems or development of practices that require judgement(s) founded on evidence, but modified or tempered by extensive clinical experience and practicalities of “real world” necessities. The articles are intended to allow you to gain greater insights into the strategies of clinical decision-making used by expert clinicians. Topics include alcohol and opioid detoxification in the ambulatory care setting, generalized anxiety disorder, mood disorders and traumatic brain injury, and seizures and new antiepileptic medications.

Psychopharmacology Pearls is an application-based continuing pharmacy education (CPE) activity. An application-based CPE activity requires that participants apply the information learned. The examination for this product often features case studies requiring that the participant apply the principles learned through the readings. Psychopharmacology Pearls includes:

  • Four (4) articles in an electronic format.
  • Five (5) hours of ACPE credit and 5 hours of BCPP Recertification credit achieved by successfully completing the online CPNP recertification examination. ACPE credit is reported to CPE Monitor at nabp.net within 48 hours after successful completion of the examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed (2020 or 2021).
  • Access to the CPNP testing center with exam submission due by May 6, 2021.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Complete the pre-test before starting the activity. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • Wait for the official review of exam questions within 4 weeks following the closing date.
  • Receive a passing grade (as determined by a panel of experts within 4 weeks following the closing date).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)
Participants successfully passing the required assessment/examination will obtain both ACPE and BCPP recertification credit. Credit is awarded in the calendar year the assessment is completed. ACPE credit is reported through CPE Monitor within days of examination submission, while BCPP recertification credit is reported to BPS within 6 weeks after the examination deadline.

Learning Objectives

Management of Treatment Resistant Generalized Anxiety Disorder

  1. Interpret clinical features and treatment issues, as applicable, to patients with complex and/or treatment resistant generalized anxiety disorder (TR-GAD).
  2. Evaluate risks and benefits of available treatment options for TR-GAD and the evidence supporting them.
  3. Apply evidence and/or expert opinion to optimize treatment for a patient with TR-GAD.
  4. Choose therapeutic management options for common or complex clinical situations with TR-GAD.

Cannabidiol in Epilepsy: The Indications and Beyond

  1. Evaluate the risks and benefits of cannabidiol in treating epilepsy and the evidence supporting them.
  2. Apply evidence and/or expert opinion to optimize treatment for a child with Dravet Syndrome or Lennox-Gastaut Syndrome.
  3. Determine if and when to use cannabidiol in off-label treatment of epilepsy using evidence and/or expert opinion.

Detoxification in an Ambulatory Care Setting

  1. Interpret clinical features and treatment issues as applicable to patients detoxifying in an ambulatory care setting. 
  2. Evaluate risks and benefits of available treatment options for detoxification in an ambulatory care setting and the evidence supporting them.
  3. Apply evidence and/or expert opinion to optimize treatment for a patient detoxifying in an ambulatory care setting.
  4. Choose therapeutic management options for common or complex detoxification in an ambulatory care setting.

Mood Disorders and Traumatic Brain Injury

  1. Interpret clinical features and treatment issues as applicable to patients with mood disorders and traumatic brain injury. 
  2. Evaluate risks and benefits of available treatment options for mood disorders and traumatic brain injury and the evidence supporting them.
  3. Apply evidence and/or expert opinion to optimize treatment for a patient with mood disorders and traumatic brain injury.
  4. Choose therapeutic management options for common or complex clinical situations with mood disorders and traumatic brain injury.

Continuing Education Credit and Disclosures

Activity Dates: 11/06/2020 - 05/06/2021
ACPE Contact Hours: 5.0
ACPE Numbers: 0284-0000-20-047-H01-P (Application), 0284-0000-20-048-H01-P (Application), 0284-0000-20-049-H01-P (Application), 0284-0000-20-050-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Psychopharmacology Pearls product is an application-based program approved for 5 ACPE contact hours. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination.

Board Certified Psychiatric Pharmacists (BCPPs) may also receive 5 hours of BCPP Recertification Credit for the Psychopharmacology Pearls upon successful completion of an online examination.